Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Andrew Cant

Newcastle AuthorsTitleYearFull text
Dr Jarmila Spegarova
Dr Karin Engelhardt
Dr Helen Griffin
Dr Aneta Mikulasova
Dr Meghan Acres
et al.		Germline TET2 loss-of-function causes childhood immunodeficiency and lymphoma2020
Dr Catriona Anderson
Dr Karin Engelhardt
Dr Zohreh Nademi
Dr Saba Habibollah
Dr Aisling Flinn
et al.		Improved transplant survival and long-term disease outcome in children with MHC class II deficiency2020
Dr Zohreh Nademi
Dr Alex Battersby
Dr Terence Flood
Dr Stephen Owens
Professor Andrew Cant
et al.		New Insights Into Risk Factors for Transplant-Associated Thrombotic Microangiopathy in Pediatric HSCT2020
Dr Sheila Waugh
Dr Lisa Newton
Dr Zohreh Nademi
Dr Stephen Owens
Professor Marieke Emonts-le Clercq
et al.		Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency2020
Dr David Swan
Dr Karin Engelhardt
Dr Rui Chen
Dr Rolando Berlinguer Palmini
Dr Tarana Singh Dang
et al.		An essential role for the Zn2+ transporter ZIP7 in B cell development2019
Professor Andrew Cant
Professor Andrew Gennery
Dr Mary Slatter
Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome2019
Professor Andrew Cant
Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients2019
Dr Zohreh Nademi
Dr Mary Slatter
Dr Mario Abinun
Dr Terence Flood
Professor Sophie Hambleton
et al.		Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency2019
Dr David Swan
Dr Chris Lamb
Savitri Pandey
Dr Karin Engelhardt
Dr Rui Chen
et al.		Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase δ2019
Dr Florian Gothe
Emeritus Professor Drew Rowan
Angela Grainger
Professor Andrew Cant
Dr Mary Slatter
et al.		Novel Gain-of-Function Mutation in Stat1 Sumoylation Site Leads to CMC/CID Phenotype Responsive to Ruxolitinib2019
1234567891011121314151617181920...